Randomized, Prospective, Double-Blind Trial of PPI vs Placebo in Prevention of Gastrojejunal Strictures After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity.

Trial Profile

Randomized, Prospective, Double-Blind Trial of PPI vs Placebo in Prevention of Gastrojejunal Strictures After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2016

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Gastric disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 May 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 25 Feb 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top